Latest News and Press Releases

GERMANTOWN, MD--(Marketwired - Aug 4, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of...

WHITE PLAINS, NY--(Marketwired - Jul 7, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian...

WHITE PLAINS, NY--(Marketwired - Jun 25, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5...

GERMANTOWN, MD--(Marketwired - May 29, 2014) - Orgenesis Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into...

WHITE PLAINS, NY--(Marketwired - Apr 21, 2014) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...

WHITE PLAINS, NY--(Marketwired - Dec 18, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...

WHITE PLAINS, NY--(Marketwired - Dec 3, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...

WHITE PLAINS, NY--(Marketwired - Nov 5, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...

SAN FRANCISCO, CA--(Marketwired - Sep 4, 2013) - Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...

WHITE PLAINS, NY--(Marketwire - May 8, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology dedicated to convert a...